Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I dose-escalation study of AZD4877 in Japanese adults with advanced solid tumors
jRCT2080220530Phase 1
- Sponsor
- AstraZeneca
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of AZD-4877 in Non-hematologic malignancy, sponsored by AstraZeneca. Primary endpoints: Safety and tolerability of weekly AZD4877 and Pharmacokinetics of AZD4877.
02
Drugs
AZD-4877
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on jRCT2080220530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220530.